Skip to main content
Bringing the Power of Computing to Biomedical Research

About CompMed

Upcoming Events

Latest News

  • Drs. Vincent and Rubinsteyn receive $40 million from OpenAI Foundation

    $40 million from the OpenAI Foundation, the non-profit parent organization that governs the for-profit company OpenAI Group PBC, to generate data that could make personalized cancer vaccines more effective…. Read More

  • Karin Liederman

    Dr. Karin Leiderman to lead Research Team

    UNC Researchers Receive $2.6 Million Grant to Study Therapies for Rare Platelet Disorders…Researchers at the University of North Carolina at Chapel Hill have received a four-year, approximately $2.6 million NIH R01 grant to study current therapies for bleeding in people with platelet disorders, including Glanzmann’s thrombasthenia (GT), a rare disorder that causes severe and sometimes … Read more

  • Katie-Hoadley

    Dr. Hoadley Oversee Large International Study

    Katherine A. Hoadley, PhD, a cancer genomics researcher at the UNC Lineberger Comprehensive Cancer Center, helped analyze data and plan and oversee a large international study that created one of the largest collections of cancer models grown from patient tumors…. Read More

Featured Faculty

YINGLONG MIAO

Dr.Yinglong Miao is an Associate Professor in the Department of Pharmacology and Computational Medicine Program.

View More

 

 

BENJAMIN VINCENT

Dr. Benjamin Vincent is an assistant professor and joint faculty member in the Department of Microbiology and Immunology at UNC-Chapel Hill. Vincent is a member of the UNC Lineberger Comprehensive Cancer Center and its Immunology Program. Vincent is part of the UNC-Chapel Hill School of Medicine’s Division of Hematology.

View More

 

 

Leadership

Charles M. Perou, PhD

The School of Medicine has launched a new Computational Medicine Program, aiming to channel UNC’s strengths in computational biology, the basic sciences, and clinical research, toward making significant advances in clinical care for patients.

The program’s co-directors are Timothy Elston, PhD, a professor of pharmacology and director of the Curriculum in Bioinformatics and Computational Biology, and Charles M. Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology at the UNC Lineberger Comprehensive Cancer Center, a professor of genetics and pathology and laboratory medicine.

“The Computational Medicine Program will enable teams of scientists from across the university to come together to address problems related to biomedical research,” Elston said. “Our ultimate goal is to generate models, combining many different types of data, that will enable us to predict outcomes of treatment and design new ways of thinking about treating disease.”